? Illicit and licit substance abuse by pregnant women is common and can lead to a number of deleterious effects in mother and her offspring. For example, risks of HIV for both mother and baby are elevated and the infant is more vulnerable to both structural defects and impaired neurodevelopment. Not only is hazardous substance use in pregnancy often undetected, but women with substance abuse and dependence frequently receive no treatment for their substance use and less than optimal amounts of prenatal care. Behavioral treatments, including motivational interviewing and relapse prevention for substance abuse, are effective for other substance abuse populations, including primary care patients. However, they have not been systematically tested in pregnant women who use cocaine, marijuana or methamphetamines. Behavioral treatments are ideal candidates to use in pregnant patients since they obviate the need for pharmacological interventions that carry their own risks of toxicity. Moreover, they can capitalize on constructive changes in health behaviors that often accompany pregnancy. Behavioral treatments delivered by the patient's obstetrical providers constitute an integrated approach that strengthens substance abuse treatment and prenatal care. In this application, we propose a randomized, controlled trial to evaluate a combined motivational and cognitive behavioral intervention for pregnant women with hazardous substance use. This trial takes advantage of the repeated prenatal visits a woman has with her clinician and provides a unique opportunity to deliver substance abuse treatment that is fully integrated with perinatal care. This would constitute the first systematic, randomized and controlled relapse prevention study to address cocaine, marijuana and other illicit substance abuse in pregnant women. We propose to: 1) conduct screening at two publicly funded perinatal clinics in Connecticut, the Yale New Haven Hospital Women's Center and the Bridgeport Hospital Prenatal Care Clinic; 2) enroll 260 women; 3) hold counseling sessions conjoint within prenatal visits; and 4) stratify for primary substance of abuse (marijuana, cocaine or alcohol). Outcomes for this study are the percentage of days the mother used any substances (primary), reduction in the HIV risk behaviors, (secondary) and assessment of fetal outcomes (secondary). ? ? ? ?

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-EXL-T (10))
Program Officer
Kahana, Shoshana Y
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Schools of Medicine
New Haven
United States
Zip Code
Loree, Amy M; Gariepy, Aileen; Ruger, Jennifer Prah et al. (2018) Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances. Subst Use Misuse 53:162-169
Smith, Megan V; Costello, Darce; Yonkers, Kimberly A (2015) Clinical correlates of prescription opioid analgesic use in pregnancy. Matern Child Health J 19:548-56
Forray, Ariadna; Merry, Brian; Lin, Haiqun et al. (2015) Perinatal substance use: a prospective evaluation of abstinence and relapse. Drug Alcohol Depend 150:147-55
Forray, Ariadna; Gotman, Nathan; Kershaw, Trace et al. (2014) Perinatal smoking and depression in women with concurrent substance use. Addict Behav 39:749-56
Yonkers, Kimberly Ann; Smith, Megan V; Forray, Ariadna et al. (2014) Pregnant women with posttraumatic stress disorder and risk of preterm birth. JAMA Psychiatry 71:897-904
Xu, Xiao; Yonkers, Kimberly A; Ruger, Jennifer P (2014) Costs of a motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice for pregnant substance users. PLoS One 9:e95264
Epperson, C Neill; Steiner, Meir; Hartlage, S Ann et al. (2012) Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 169:465-75
Yonkers, Kimberly A; Forray, Ariadna; Howell, Heather B et al. (2012) Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery. Gen Hosp Psychiatry 34:439-49
Yonkers, Kimberly A; Norwitz, Errol R; Smith, Megan V et al. (2012) Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology 23:677-85
Quesada, Odayme; Gotman, Nathan; Howell, Heather B et al. (2012) Prenatal hazardous substance use and adverse birth outcomes. J Matern Fetal Neonatal Med 25:1222-7

Showing the most recent 10 out of 18 publications